An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator

Journal of Experimental Medicine

Volumn 185, Issue 11, 1997, Pages 1885-1895

  Douhan III, John ^a,b   Lieberson, Rebecca ^a   Knoll, Joan H M ^c   Zhou, Hong ^a   Glimcher, Laurie H ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; DNA PRIMERS; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MUTATION; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030975147     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.11.1885     Document Type: Article

References (46)

1. Schwartz, R.H. 1986. Immune response (Ir) genes of the murine major histocompatibility complex. Adv. Immunol. 38: 31-201.
2. Glimcher, L.H., and C.J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10: 13-49.
3. Paulnock-King, D., K.C. Sizer, Y.R. Freund, P.P. Jones, and J.R. Parnes. 1985. Coordinate induction of Ia alpha, beta, and Ii mRNA in a macrophage cell line. J. Immunol 135: 632-636.
4. de Preval, C., M.R. Hadam, and D. Mach. 1988. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. N. Engl. J. Med. 318:1295-1300.
5. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681-715.
6. Accolla, R.S., G. Carra, and J. Guardiola. 1985. Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma. Prof. Natl. Acad. Sci. USA. 82:5145-5149.
7. Yang, Z., R.S. Accolla, D. Pious, B.J. Zegers, and J.L. Strominger. 1988. Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines. EMBO (Eur. Mol. Biol. Organ.) J. 7:1965-1972.
8. Hume, C.R., and J.S. Lee. 1989. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum. Immunol. 26:288-309.
9. Benichou, B., and J.L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA. 88:4285-4288.
10. Peijnenburg, A., B. Godthelp, A. van Boxel-Dezaire, and P.J. van den Elsen. 1995. Definition of a novel complementation group in MHC class II deficiency. Immunogenetics. 41:287-294.
11. Douhan, J., J.A. Brown, Z.L. Gleit, C.S. David, and L.H. Glimcher. 1996. Regulation of the E-beta gene in vivo: lessons from E(beta)(D) transgenic mice. Int. Immunol. 8:255-265.
12. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease Annu. Rev. Immunol. 14:301-331.
13. Steimle V., L.A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 75:135-146.
14. Steimle V., B. Durand, E. Barras, M. Zufferey, M.R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021-1032.
15. Ono, S.J., V. Bazil, M. Sugawara, and J.L. Strominger. 1991. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J. Exp. Med. 173:629-637.
16. Zhou, H., and L.H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity. 2:545-553.
17. Ono, S.J., and Z. Song. 1995. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box. J. Biol. Chem. 270:6396-6402.
18. Accolla, R.S. 1983. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets J. Exp. Med. 157:1053-1058.
19. Zhou, H., H.S. Su, X. Zhang, J. Douhan III, and L.H. Glimcher. 1997. CIITA-dependent and independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. In press.
20. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
21. Seabright, M. 1971. A rapid banding technique for human chromosomes. Lancet. 2:971-972.
22. Knoll, J.H.M., and P. Lichter. 1994. In situ hybridization to metaphase chromosomes and interphase nuclei. In Current protocols in human genetics. Vol. 1. N.C. Dracopoli, J.L. Haines B.R. Korf, D.T. Moir, C.C. Morton, C.E. Seidman and J.G. Seidman, editors. Green-Wiley, New York. 4.3.1-4.3.28.
23. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
24. Nomura N., M. Ota, K. Tsuji, and H. Inoko. 1991. HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens. 38:53-59.
25. Riley, J.L., S.D. Westerheide, J.A. Price, J.A. Brown, and J.M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:533-543.
26. Brown, J.A., X.F. He, S.D. Westerheide, and J.M. Boss. 1996. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5. Immunogenetics. 43:88-91.
27. Reith, W., V. Steimle, and B. Mach. 1995. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol. Today. 16:539-546.
28. Liou, H.C., M.R. Boothby, P.W. Finn, R. Davidon, N. Nabavi, N.J. Zeleznik-Le, J.P. Ting, and L.H. Glimcher. 1990. A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (Wash. DC). 247:1581-1584.
29. Liou, H.C., M.R. Boothby, and L.H. Glimcher. 1988. Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element. Science (Wash. DC). 242: 69-71.
30. Ivashkiv L.B., H.C. Liou, C.J. Kara, W.W. Lamph, I.M. Verma, and L.H. Glimcher. 1990. mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Mol. Cell. Biol. 10:1609-1621.
31. Andersson, G., and B.M. Peterlin. 1990. NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun J. Immunol. 145:3456-3462.
32. Hasegawa, S.L., and J.M. Boss. 1991. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res. 19:6269-6276.
33. Ono, S.J., H.C. Liou, R. Davidon, J.L. Strominger, and L.H. Glimcher. 1991. Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc. Natl. Acad. Sci. USA. 88:4309-4312.
34. Reimold, A.M., M.J. Grusby, B. Kosaras, J.W. Fries, R. Mori, S. Maniwa, I.M. Clauss, T. Coffins, R.L. Sidman, M.J. Glimcher, and L.H. Glimcher. 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (Lond.). 379:262-265.
35. Moreno, C.S., P. Emery, J.E. West, B. Durand, W. Reith, B. Mach and J.M. Boss. 1995. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313-4321.
36. Chang, C.H., J.D. Fontes, M. Peterlin, and R.A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374.
37. Steimle, V., C.A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science (Wash. DC). 265:106-109.
38. Silacci, P., A. Mottet, V. Steimle, W. Reith, and B. Mach. 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1329-1336.
39. Chang, C.H., S.C. Hong, C.C. Hughes, C.J. Janeway, and R.A. Flavell. 1995. CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol. 7:1515-1518.
40. Chang C.H., S. Guerder, S.C. Hong, W. van Ewijk, and R.A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:167-178.
41. Calman, A.F., and B.M. Peterlin. 1987. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol. 139:2489-2495.
42. Heston, L., M. Rabson, N. Brown, and G. Miller. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature (Lond.). 295:160-163.
43. Blanck, G., M. Lok, K. Kok, E. Downie, J.H. Korn, and J.L. Strominger. 1990. Gamma-interferon induction of HLA class II mRNAs in dermal fibroblasts studied by RNAse protection analysis. Hum. Immunol. 29:150-156.
44. Pesando, J.M., and L. Graf. 1986. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells. J. Immunol. 136:4311-4318.
45. Pesando, J.M., L. Graf, and P. Hoffman. 1986. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line. J. Immunol. 137:1932-1936.
46. Lucey, D.R., A. Nicholson-Weller, and P.P. Weller. 1989. Mature human eosinophils have the capacity to express HLA-DR. Prac. Natl. Acad. Sci. USA. 86:1348-1351.